...
首页> 外文期刊>BMC Genomics >Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme
【24h】

Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme

机译:使用块自举重采样方案从微阵列数据中选择DDX5作为Q-RT-PCR的新型内部对照

获取原文
           

摘要

Background The development of microarrays permits us to monitor transcriptomes on a genome-wide scale. To validate microarray measurements, quantitative-real time-reverse transcription PCR (Q-RT-PCR) is one of the most robust and commonly used approaches. The new challenge in gene quantification analysis is how to explicitly incorporate statistical estimation in such studies. In the realm of statistical analysis, the various available methods of the probe level normalization for microarray analysis may result in distinctly different target selections and variation in the scores for the correlation between microarray and Q-RT-PCR. Moreover, it remains a major challenge to identify a proper internal control for Q-RT-PCR when confirming microarray measurements. Results Sixty-six Affymetrix microarray slides using lung adenocarcinoma tissue RNAs were analyzed by a statistical re-sampling method in order to detect genes with minimal variation in gene expression. By this approach, we identified DDX5 as a novel internal control for Q-RT-PCR. Twenty-three genes, which were differentially expressed between adjacent normal and tumor samples, were selected and analyzed using 24 paired lung adenocarcinoma samples by Q-RT-PCR using two internal controls, DDX5 and GAPDH. The percentage correlation between Q-RT-PCR and microarray were 70% and 48% by using DDX5 and GAPDH as internal controls, respectively. Conclusion Together, these quantification strategies for Q-RT-PCR data processing procedure, which focused on minimal variation, ought to significantly facilitate internal control evaluation and selection for Q-RT-PCR when corroborating microarray data.
机译:背景技术微阵列的发展使我们能够在全基因组范围内监测转录组。为了验证微阵列测量,定量实时逆转录PCR(Q-RT-PCR)是最可靠且最常用的方法之一。基因定量分析的新挑战是如何在这些研究中明确纳入统计估计。在统计分析领域,用于微阵列分析的探针水平归一化的各种可用方法可能会导致目标选择的明显不同以及微阵列与Q-RT-PCR之间相关性的得分变化。此外,在确认微阵列测量结果时,为Q-RT-PCR鉴定合适的内部对照仍然是一项重大挑战。结果通过统计重采样方法分析了使用肺腺癌组织RNA的66个Affymetrix微阵列玻片,以检测基因表达差异最小的基因。通过这种方法,我们将DDX5确定为Q-RT-PCR的新型内部对照。选择了23个在相邻正常样本和肿瘤样本之间差异表达的基因,并使用24个成对的肺腺癌样本通过Q-RT-PCR(使用两个内部对照DDX5和GAPDH)进行了分析。使用DDX5和GAPDH作为内部对照,Q-RT-PCR与微阵列之间的百分比相关性分别为70%和48%。结论这些Q-RT-PCR数据处理程序的量化策略(以最小的变化为重点)在证实微阵列数据时应显着促进Q-RT-PCR的内部控制评估和选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号